Monroe Capital Backs Battery Ventures' Investment in Phigenics

Monroe Capital has provided financing to support Battery Ventures' investment in Phigenics, according to an announcement distributed via Business Wire.

The deal positions Monroe Capital as a financing partner to Battery Ventures, the technology-focused private equity firm, in its investment in Phigenics, a company known for its work in water management and water safety programs.

What do we know about the transaction?

Business Wire reported that Monroe Capital supported Battery Ventures' investment in Phigenics. The announcement names three parties:

• Monroe Capital, the Chicago-based private credit asset management firm, acting as a financing provider in the transaction.
• Battery Ventures, the multi-stage investment firm, as the investor in Phigenics.
• Phigenics, the portfolio company receiving the investment.

Monroe Capital regularly provides debt financing to support private equity sponsor transactions, and this deal fits that pattern: the firm supplied capital alongside Battery Ventures' equity investment in Phigenics.

Who are the parties?

Monroe Capital is a private credit asset management firm that specializes in financing solutions for middle-market companies and private equity sponsors. Its involvement in sponsored transactions typically takes the form of debt facilities that support acquisitions, recapitalizations and growth investments.

Battery Ventures is a technology-oriented investment firm that invests at stages ranging from venture to buyout. Its decision to invest in Phigenics extends its portfolio into the water-technology and facility-services segment.

Phigenics provides water management services, helping organizations manage water safety and reduce water-related risk in buildings and facilities — a category that has drawn growing attention from property operators and institutional investors focused on compliance and operational risk.

Why does private credit financing matter here?

Monroe Capital's participation reflects the role of private credit firms in mid-market private equity deals. Direct lenders frequently supply the debt component of sponsor-led investments, offering faster execution and more flexible structures than syndicated bank financing.

For Battery Ventures, securing financing from an established private credit manager supports the capital structure of the Phigenics transaction. For Monroe Capital, the deal adds another sponsor relationship in the services and technology space.

What comes next?

Additional detail on the transaction — including the investment amount, deal structure and Phigenics' growth plans under Battery Ventures' ownership — has not been disclosed in the announcement. Readers should watch for follow-on statements from Battery Ventures and Phigenics regarding strategy, leadership and any add-on acquisition plans following the investment.